Share

August 29, 2017; 89 (9) Article

Activity limitations and subjective well-being after stroke

Darin B. Zahuranec, Lesli E. Skolarus, Chunyang Feng, Vicki A. Freedman, James F. Burke
First published July 21, 2017, DOI: https://doi.org/10.1212/WNL.0000000000004286
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
185

Share

Article Information

vol. 89 no. 9 944-950
DOI: 
https://doi.org/10.1212/WNL.0000000000004286
PubMed: 
28733341
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 3, 2016
  • Accepted in final form June 6, 2017
  • First Published July 21, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Darin B. Zahuranec, MD,
    2. Lesli E. Skolarus, MD,
    3. Chunyang Feng, PhD,
    4. Vicki A. Freedman, PhD and
    5. James F. Burke, MD
  1. Darin B. Zahuranec, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Medtronic

    Research Support, Government Entities:

    1. (1) NIH/NIA [#K23 AG038731] (PI) 2011-present (2) NIH/NINDS [#R01 NS09112] (PI) 2015-present (3) NIH/NIA [#R01AG051827] (Co-I) 2016-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Lesli E. Skolarus, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Brackett Global

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Travel to ANA/NINDS K23 conference via ANA/NINDS

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NINDS K23NS073685, R01MD008879, R21NS084081, U01MD010579

    Research Support, Academic Entities:

    1. Receives institutional support from the University of Michigan for stroke-related research projects. Blue Cross Blue Shield of Michigan Foundation

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Chunyang Feng, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Vicki A. Freedman, PhD and
    5. Scientific Advisory Boards:

    1. (1) Non-profit entity: The National Academies of Sciences, Engineering, and Medicine, Committee on Population

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Non-profit entity: The National Academies of Sciences, Engineering, and Medicine, Committee on National Statistics (travel)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Public Health and Aging, 2nd edition, Springer Publishing Company, 2010

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIA R01-AG054004 Multiple Principal Investigator; 09/16 ? 06/21 (2) NIA P30-AG012846 Co-Director 08/14-06/19 (3) NIA U01-AG032947 Co-Principal Investigator 9/08- 6/19 (4) NIA P01-AG029409 Principal Investigator 12/12- 11/17 (5) NIA R01-AG040213 Principal Investigator 9/16-9/21 (6) NIMHD R01-MD008879 Co-Investigator 7/14-3/19 (7) NIH R01-AG040635 Co-Investigator 07/11-06/16 (8) NICHD U24-HD048404 Principal Investigator 9/14- 11/19 Immediate Family Member

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. James F. Burke, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. American Academy of Neurology, Continuum Article

    Editorial Boards:

    1. 1. Associate Editor at Circulation: Cardiovascular Quality and Outcomes from 7/2016-current

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Dr. Burke has received compensation from Astra Zeneca for his role as an adjudicator in the SOCRATES trial.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Dr. Burke is funded by NIH K08 NS082597 and R01 MD008879.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Dr. Burke has reviewed case materials in a medical malpractice defense case.

  1. From the Stroke Program, Department of Neurology (D.B.Z., L.E.S., C.F., J.F.B.), and Institute for Social Research (V.A.F.), University of Michigan, Ann Arbor.
  1. Correspondence to Dr. Zahuranec: zdarin{at}umich.edu
View Full Text

Article usage

Article usage: July 2017 to May 2023

AbstractFullPdfSource
Jul 2017823016Highwire
Aug 2017876627Highwire
Sep 2017534712Highwire
Oct 201724757Highwire
Nov 201719842Highwire
Dec 201715942Highwire
Jan 201811877Highwire
Feb 2018861214Highwire
Mar 20187389Highwire
Apr 20186731Highwire
May 20185411Highwire
Jun 20185111Highwire
Jul 20187212Highwire
Aug 20184411Highwire
Aug 2018011pmc
Sep 20187400Highwire
Oct 20189000Highwire
Nov 20185423Highwire
Dec 20186143Highwire
Jan 20195012Highwire
Feb 20196500Highwire
Mar 20197533Highwire
Apr 20198525Highwire
May 20193311Highwire
Jun 20192912Highwire
Jul 20194712Highwire
Aug 20192830Highwire
Sep 20193102Highwire
Oct 20193412Highwire
Nov 20192502Highwire
Dec 20192400Highwire
Jan 20204114Highwire
Feb 20204402Highwire
Mar 20203803Highwire
Apr 202010225Highwire
May 202037501Highwire
Jun 202060100Highwire
Jul 202031000Highwire
Aug 20203901Highwire
Sep 20205652Highwire
Oct 20206310Highwire
Nov 20205642Highwire
Dec 20205620Highwire
Jan 20215502Highwire
Feb 20213621Highwire
Mar 20215211Highwire
Apr 20215111Highwire
May 20214300Highwire
Jun 20213110Highwire
Jul 20214521Highwire
Aug 20213800Highwire
Sep 20215200Highwire
Oct 20214002Highwire
Nov 20218500Highwire
Dec 20216222Highwire
Jan 202212212Highwire
Feb 20225711Highwire
Mar 20223801Highwire
Apr 20223653Highwire
May 20225912Highwire
Jun 20224822Highwire
Jul 20222111Highwire
Aug 20224811Highwire
Sep 20226526Highwire
Oct 20223610Highwire
Nov 20224421Highwire
Dec 20221711Highwire
Jan 20232900Highwire
Feb 20235511Highwire
Mar 20234211Highwire
Apr 20232801Highwire
May 20236411Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles